Isabelle Fonta

Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate

Mathieu Gendrot, Isabelle Duflot, Manon Boxberger et al. · International Journal of Infectious Diseases · 2020 · 106 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +17

Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation

Mathieu Gendrot, Julien Andréani, Manon Boxberger et al. · Travel Medicine and Infectious Disease · 2020 · 106 citations · Full text

Medicine, Infectious Diseases, Pharmacology +12

In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2

Mathieu Gendrot, Julien Andréani, Priscilla Jardot et al. · Molecules · 2020 · 94 citations · Full text

Medicine, Infectious Diseases, Pharmacology +16

Methylene blue inhibits replication of SARS-CoV-2 in vitro

Mathieu Gendrot, Julien Andréani, Isabelle Duflot et al. · International Journal of Antimicrobial Agents · 2020 · 68 citations · Full text

Life Sciences, Molecular Biology, Molecular Virology +4

Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates

Francis Tsombeng Foguim, Hervé Bogreau, Mathieu Gendrot et al. · Malaria Journal · 2020 · 35 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17